CD10 10mg*10vials

CJC 1295 with DAC CD10 10mg*10vials

CJC 1295 is a growth hormone releasing hormone analog designed to stimulate the pituitary gland's natural growth hormone production. This version with DAC (Drug Affinity Complex) has an extended half-life, providing sustained growth hormone release over several days, representing a high-concentration long-acting research peptide in endocrine and recovery studies.

The 10mg single-vial specification delivers five times the active ingredient content of the standard 2mg. This formulation is ideal for long-term endocrine studies, high-dose sustained GH pathway experiments, and researchers conducting extended large-animal research. The higher concentration per vial significantly reduces the number of vials needed for prolonged experiments, minimizing handling variables and operational errors from repeated dilution.

Through its targeted GHRH receptor pathway, CJC 1295 supports in-depth research into natural growth hormone release, muscle growth, fat metabolism, recovery, and sleep quality. The DAC version is designed to study the effects of continuous, elevated GH secretion patterns on physiological processes, offering a distinct research profile compared to short-acting variants.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Every batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for long-term preclinical research and high-intensity endocrine laboratory projects.